Gemcitabine-resistant CCA cell lines, developed through stepwise long-term exposure, showed upregulation of proteins related to drug resistance mechanisms, including increased MRP1 expression, activation of the PKC signaling pathway, and NF-κB activation [41]. The gene discussed is NFKB1; the disease is cholangiocarcinoma.